SUAREZ CUENCA, JUAN ANTONIO
CIENCIAS MÉDICAS · Nivel 2
Desde 2012 es Researcher en Centro Médico Nacional 20 de Noviembre
Información*
| Nombre | JUAN ANTONIO SUAREZ CUENCA |
|---|---|
| Área | MEDICINA Y CIENCIAS DE LA SALUD |
| Campo | CIENCIAS MÉDICAS |
| Disciplina | INVESTIGACIÓN CLÍNICA |
| Especialidad | GASTROENTEROLOGIA |
| CVU | 36854 |
| Institución | |
|---|---|
| Dependencia | CENTRO MEDICO NACIONAL 20 DE NOVIEMBRE |
| Entidad | CIUDAD DE MEXICO |
| Nivel | 2 |
| Vigencia | Inicio: 01/01/2025 |
| Fin: 31/12/2029 |
* Información del primer trimestre de 2026.
Fuente: SECIHTI.
Publicaciones ORCID
- 2026
- Gaze-Tracking-Based Tests for Autism in Children: A Diagnostic Test Accuracy Systematic Review and Meta-Analysis Autism
- Gene expression in visceral adipocytes in metabolically healthy and unhealthy obesity: A cross-sectional analysis of associations with cardiometabolic components Science Progress
- Association of Sarcopenia with Lower Adiponectin Levels and Reduced Estimated Appendicular Lean Mass in Patients with Metabolic Syndrome: A Cross-Sectional Study Diseases
- 2025
- Mycobacterium tuberculosis Infects Human Visceral White Adipocytes and Expresses Dormancy Genes and Inflammatory Cytokines: The Role of Visceral Adipocytes in Latent Tuberculosis Infection International Journal of Molecular Sciences
- Tomographic features of lung damage associate with D-Dimer levels and further clinical outcome in patients with acute respiratory distress syndrome due to COVID-19 BMC Pulmonary Medicine
- 2023
- Nonalcoholic Fatty Liver Disease Severity Is Related to Plasma Pro-Oxidative Biomarkers Rather Than Liver Tissue-Measured Nitrogen Metabolism Biomarkers in Population with Obesity and Metabolic Syndrome Metabolic Syndrome and Related Disorders
- NAMPT INHIBITION AND INCREASED NAD-BIOAVAILABILITY ATENUATE LIVER DAMAGE IN CCl4-INDUCED MICE LIVER FIBROSIS
- 2022
- The metabolic phenotype of the patient influences the reduction in carotid intima-media thickness achieved following metabolic surgery Journal of International Medical Research
- 2021
- Urine transferrin as an early endothelial dysfunction marker in type 2 diabetic patients without nephropathy: a case control study Diabetology & Metabolic Syndrome
- Urine Transferrin as an Early Endothelial Dysfunction Marker in Type 2 Diabetic Patients Without Nephropathy: A Case Control Study.
